Sales increase at Sientra but so do net losses

You are here: Home > Biotech > Current Article

By Staff Report / Wednesday, May 8th, 2019 / Comments Off on Sales increase at Sientra but so do net losses

Net sales for Sientra jumped 20 percent in the first quarter, but net losses grew even faster, up 36.5 percent to $26.5 million, or 91 cents per share, missing analyst estimates. The Goleta breast implant manufacturer said its breast products saw a 14 percent increase compared to the same period the prior year, to $8.5…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.